A UK inquiry finds that around 23,000 deaths in England could have been prevented if the national lockdown had begun a week earlier in March 2020, highlighting major government failings during the pandemic.
Abbas Kanani, Superintendent Pharmacist at Chemist Click Online Pharmacy, walks us through treatments for Alzheimer’s disease, researching the causes, diagnosis, prevention, and cure.
Abbas Kanani, Superintendent Pharmacist at Chemist Click Online Pharmacy, walks us through what we need to know about living with diabetes, starting with a comment on prediabetes.
Dr Joana Torres, Gastroenterologist, Expert in Clinical IBD and UEG* Rising Star Awardee, highlights the most challenging aspects of living with inflammatory bowel disease and the unmet medical needs in IBD management.
Efforts to prevent or treat Alzheimer’s Disease (AD) by targeting Amyloid beta (Aβ) assemblies should be continued, but the strategies should be altered dramatically.
HPV is the most common STI in the world, affecting 80% of the population. Here Dr Deborah Lee, from Dr Fox Online Pharmacy, addresses the most common issues about HPV in an attempt to aid in the understanding of the condition
Christen Richards, Committee Member from MS Society Jersey, unpacks multiple sclerosis symptoms for us, focusing on recognising the key points to help the diagnostic process.
Dr Zisis Kozlakidis directs our thoughts towards the molecular aspects of global Infection Prevention and Control, in this the second of a special two-part series.
In this interview, Abbas Kanani, MRPharmS, Superintendent Pharmacist at Chemist Click, tells us about amyloidosis, a group of rare diseases in which abnormal proteins deposit as amyloid in tissues and organs.
Wendy Harrison, CEO of the SCI Foundation, outlines the importance of putting parasitic infections on the map, with a particular focus on schistosomiasis.
Researchers are developing a new Alzheimer's disease detection sensor that can be used in the early stages of Alzheimers and a number of other diseases.
Dr. Gerardo Fernandez, CSO ViewMind Inc, investigates how early is too early for the detection of Alzheimer’s disease and how soon in the disease’s trajectory detection can make a meaningful difference in a patient’s prognosis.
